Tigecycline NEW
| Price | $32 | $52 | $72 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-25 |
Product Details
| Product Name: Tigecycline | CAS No.: 220620-09-7 |
| Purity: 99.32% | Supply Ability: 10g |
| Release date: 2026/05/25 |
Product Introduction
Bioactivity
| Name | Tigecycline |
| Description | Tigecycline (GAR-936) is a broad-spectrum glycylcycline antibiotic derived from tetracycline that binds to the 30S ribosomal subunit, disrupting the binding of aminoacyl-tRNA to the mRNA-ribosome complex. |
| In vitro | Tigecycline inhibited methicillin-resistant Staphylococcus aureus in a rabbit model of osteomyelitis. Tigecycline was shown to be resistant to Legionella pneumophila in guinea pigs with Legionella pneumophila pneumonia. |
| In vivo | Tigecycline, a substrate for the tetracycline-specific efflux pump, exhibits antibacterial activity against a wide range of aerobic and anaerobic bacteria. For enterococci, staphylococci and streptococci (MIC=0.06-0.25 mg / L), Tigecycline was able to produce bacteriostatic effects. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol : < 1 mg/mL (insoluble or slightly soluble) DMSO : 93 mg/mL (158.8 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.3 mg/mL (5.63 mM), Sonication is recommended. H2O : 92 mg/mL (157.09 mM), Sonication is recommended. |
| Keywords | Tigecycline | Inhibitor | inhibit | GAR936 | GAR 936 | Bacterial | Autophagy | Antibiotic | 30S ribosome |
| Inhibitors Related | Neomycin sulfate | Aceglutamide | Hemin | D(+)-Raffinose pentahydrate | Guanidine hydrochloride | Sulfamethoxazole sodium | Terbinafine hydrochloride | Hydroxychloroquine | Hyaluronic acid sodium (MW 20 kDa) | Dimethyl sulfoxide | Sodium diacetate | Sodium bicarbonate |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Bioactive Compound Library | Approved Drug Library | EMA Approved Drug Library | Toxic Compound Library | Autophagy Compound Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-08 | ||
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-08 | ||
| $1.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
|
Hebei Yanxi Chemical Co., Ltd.
|
2025-06-20 | |||
|
VIP3Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2025-04-02 | ||
| $15.00 |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-27 | ||
| $1.00 |
Wuhan Dujiang Industrial Co., Ltd.
|
2023-04-12 | ||
|
Senova Technology Co. Ltd.
|
2022-10-14 | |||
| $5.00 |
Qiuxian Baitai New Material Co., LTD
|
2021-11-27 | ||
| $9.00 |
Shijiazhuang tongyang Import and Export Co., LTD
|
2021-08-14 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY